Hypoxemia during bronchoscopy
Conditions
Interventions
Group S:Sufentanil 0.2ug/kg was given intravenously for 20s-30s during the induction period.
E group:During the induction period, 0.2 mg/kg of esketamine was given by slow intravenous injection for 20 s to 30 s.
Sponsors
Ganzhou People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1.A clear record of "difficult intubation" or "difficult mask ventilation", a history of asthma, and a history of obstructive sleep apnea (OSA) in previous anesthesia records; 2.Positive on any of the following physical examinations: Mallampati III-IV, mouth opening < 3 cm, mento-hyoid distance/mandibular retrusion,Limited mandibular protrusion, limited neck mobility, snoring, increased neck circumference (e.g. BMI = 30 and neck circumference = 40 cm), tongue hypertrophy, edentulous; 3.Cervical and facial anatomical abnormalities/airway lesions (airway tumors, airway stenosis, radiotherapy scars, etc.); 4.other inclusion: age = 18 years and < 75 years, American Society of Anesthesiologists (ASA) grade I ~ III, electronic/fiberoptic bronchoscopy is to be performed, sedation/anesthesia cooperation is required, and informed consent is signed;
Exclusion criteria
Exclusion criteria: 1.Patients who need urgent airway establishment; 2.Patients with "catastrophic upper respiratory tract pathology" (such as huge laryngeal mass with resting laryngeal stridor, severe tracheal stenosis 40 kg/m ²) and severe OSA syndrome; 5.Patients unable to provide informed consent; 6.Patients with operation duration > 60 min.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hypoxemia; | — |
Countries
China
Contacts
Public ContactHuang Guiming
Ganzhou People's Hospital
Outcome results
None listed